Panome Bio

Panome Bio is a rapidly growing biotechnology CRO specializing in next-generation metabolomics, lipidomics, proteomics, and phosphoproteomics. Their proprietary mass spectrometry-based platforms enable comprehensive multiomic profiling for biomarker discovery and mechanistic insights into health and disease. They serve biopharma innovators with advanced workflows for metabolic flux analysis, targeted metabolite quantification, global proteomic surveys—including phosphorylation events—and integrated bioinformatics pipelines. The company’s technologies have been applied to research in cancer biology, aging processes, drug metabolism studies, and more.